Wagner, Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency, Am
Reported safety observations from published studies indicate that intravenous ALA has generally been well tolerated under the specific doses and conditions studied, although adverse events have been documented and can vary depending on dose, patient characteristics, and study design
According to a 2017 systematic review in the Journal of Clinical Nursing confirming that aspiration before subcutaneous injection does not reduce adverse events, subcutaneous injections carry a distinct pharmacokinetic profile that intramuscular delivery disrupts, which is why correct angle and depth matter for predictable results
For real
10.1093/bioinformatics/btv362 98 LoveA
If youve had experience with GHK-Cu, whether as a clinician, a researcher, or someone simply curious about optimizing healthspan, Id love to hear your perspective